knowledge -WSS

knowledge

author：comprehensive 2025-09-30 14:08:46 - browse：69375

Teleflex announced plans on Wednesday to acquire Palette Life Sciences, the maker of a slate of gel-based products treating urological disorders. The vascular device manufacturer will pay $600 million upfront, and plans to use Palette’s portfolio to treat more urinary tract and reproductive health conditions.

Palette will bring Teleflex an extra $56 million in sales, the company estimated in a press release. Teleflex develops a range of devices, but makes the most money from vascular products like catheters. The company offers just one urological treatment: the UroLift system to relieve an enlarged prostate. With Palette, it will gain five more treatments all built from hyaluronic acid, a stretchy material that’s meant to last longer in the human body.

Palette’s highest-revenue device is Barrigel, which helps protect the rectum from harsh radiation administered to prostate cancer patients. It eases symptoms like bladder inflammation, bleeding, and diarrhea. The device received FDA clearance in May 2022 through the 510(k) process, which allowed Palette to claim the product was equivalent to a rectal radiation protector sold by Boston Scientific. Boston Scientific has sold that device since 2018, when it acquired it by buying the startup Augmenix for $500 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： UnitedHealth’s Optum accused of antitrust violations in California

entertainment

leisure time

WSS

Fetal surgery at risk from Dobbs and new abortion restrictions

J&J to emphasize cancer drugs, stop much of its vaccine research

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Organ aging and disease risk measured by new blood test

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Wikipedia

knowledge

leisure time

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Recent heat wave in the Mediterranean caused by climate change: Study

After affirmative action ruling, medical educators look to 'holistic review'

What don’t we know about an Alzheimer’s drug side effect?

Duchenne breakthrough therapy leaves behind pioneering families

Pediatric cancer treatments threatened by a new FDA policy

Trump demands the U.S. pay no more for drugs than other countries … again

Judge agrees to delay next hearing in Trump classified documents case

Peter Hotez and the public health issue of online harassment

ReNAgade cuts staff seven months after raising $300 million

focus

Pandemic and All Hazards Preparedness Act needs lean update

Biden targets hefty hospital 'facility fees' that often surprise patients

Home health providers sue Medicare over payment cuts

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Cigna, Humana reportedly in talks to merge

Flagship Pioneering launches a new biotech in two countries

entertainment

leisure time

focus

entertainment